These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3013476)

  • 1. Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infection.
    Sandstrom IK; Foster CS; Wells PA; Knipe D; Caron L; Greene MI
    Clin Immunol Immunopathol; 1986 Aug; 40(2):326-34. PubMed ID: 3013476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation of experimental murine herpes simplex keratitis: I. UV-HSV protection.
    Thompson P; Wells PA; Sandstrom IK; Opremcak EM; Millin JA; Daigle JA; Foster CS
    Curr Eye Res; 1988 Nov; 7(11):1043-9. PubMed ID: 2854036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection.
    Foster CS; Sandstrom IK; Wells PA; Thompson P; Daigle J; Opremcak EM
    Curr Eye Res; 1988 Nov; 7(11):1051-61. PubMed ID: 2854037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic studies on murine susceptibility to herpes simplex keratitis.
    Foster CS; Tsai Y; Monroe JG; Campbell R; Cestari M; Wetzig R; Knipe D; Greene MI
    Clin Immunol Immunopathol; 1986 Aug; 40(2):313-25. PubMed ID: 3013475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetic influence of Igh-1 phenotype on experimental herpes simplex virus type-1 corneal infection.
    Opremcak EM; Wells PA; Thompson P; Daigle JA; Rice BA; Millin JA; Foster CS
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):749-54. PubMed ID: 3366566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
    Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type-1 strain influence on chorioretinal disease patterns following intracameral inoculation in Igh-1 disparate mice.
    Hemady R; Opremcak EM; Zaltas M; Berger A; Foster CS
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1750-7. PubMed ID: 2547732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity against herpetic ocular disease in an outbred mouse model.
    Metcalf JF; Whitley RJ
    Curr Eye Res; 1987 Jan; 6(1):167-71. PubMed ID: 3030641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histology and immunohistology of Igh-1-restricted herpes simplex keratitis in BALB/c congenic mice.
    Opremcak EM; Rice BA; Wells PA; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):305-12. PubMed ID: 2154415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.
    Shimeld C; Hill TJ; Blyth WA; Easty DL
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():681-7. PubMed ID: 2156001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection from experimental ocular herpetic keratitis by a heat-killed virus vaccine.
    Metcalf JF
    Arch Ophthalmol; 1980 May; 98(5):893-6. PubMed ID: 6246863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
    Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
    Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease.
    Hendricks RL; Weber PC; Taylor JL; Koumbis A; Tumpey TM; Glorioso JC
    J Gen Virol; 1991 Jul; 72 ( Pt 7)():1601-10. PubMed ID: 1649898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
    Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.
    Royer DJ; Gurung HR; Jinkins JK; Geltz JJ; Wu JL; Halford WP; Carr DJJ
    J Virol; 2016 Jun; 90(11):5514-5529. PubMed ID: 27030264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology.
    Hendricks RL; Tumpey TM
    Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1929-39. PubMed ID: 2170289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with DNA vaccine expressing herpes simplex virus type 1 gD and IL-21 protects against mouse herpes keratitis.
    Hu K; He X; Yu F; Yuan X; Hu W; Liu C; Zhao F; Dou J
    Immunol Invest; 2011; 40(3):265-78. PubMed ID: 21204603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoproteins.
    Metcalf JF; Chatterjee S; Koga J; Whitley RJ
    Intervirology; 1988; 29(1):39-49. PubMed ID: 2838428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity.
    Lausch RN; Kleinschradt WR; Monteiro C; Kayes SG; Oakes JE
    Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1509-15. PubMed ID: 2997073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.